53
Preoperative Evaluation and Management with Cardiac Evaluation Lauren Hojdila, MSA, AA-C Nova Southeastern University

Preoperative Evaluation and Management with Cardiac Evaluation Lauren Hojdila, MSA, AA-C Nova Southeastern University

Embed Size (px)

Citation preview

Page 1: Preoperative Evaluation and Management with Cardiac Evaluation Lauren Hojdila, MSA, AA-C Nova Southeastern University

Preoperative Evaluationand Management with Cardiac

Evaluation

Lauren Hojdila, MSA, AA-CNova Southeastern University

Page 2: Preoperative Evaluation and Management with Cardiac Evaluation Lauren Hojdila, MSA, AA-C Nova Southeastern University

The Preoperative EvaluationA Standard of Care

• The Joint Commission for the Accreditation of Healthcare Organizations (TJC) requires that all patients receive a preoperative anesthetic evaluation

• The American Society of Anesthesiologists (ASA) has approved Basic Standards for Pre-Anesthetic Care, which outlines the minimum requirements for a preoperative evaluation

Page 3: Preoperative Evaluation and Management with Cardiac Evaluation Lauren Hojdila, MSA, AA-C Nova Southeastern University

Goals of the Preoperative Evaluation

• Primary Goals– Reduce patient risk– Reduction of perioperative morbidity and

mortality

• Secondary Goals– Promote efficiency– Reduce costs

*Conducting a preoperative evaluation is based on the premise that it will modify patient care and improve outcome.

Page 4: Preoperative Evaluation and Management with Cardiac Evaluation Lauren Hojdila, MSA, AA-C Nova Southeastern University

Does the Preoperative Evaluation alter Patient Care ?

• Gibby et al found that anesthetic plans were altered in 20% of all patients due to conditions identified at the preoperative evaluation

• The most common conditions resulting in modification of the anesthetic plan were gastric reflux, IDDM, asthma, and suspected difficult airway

• These findings indicate the need to do the initial preoperative evaluation before the day of surgery

Page 5: Preoperative Evaluation and Management with Cardiac Evaluation Lauren Hojdila, MSA, AA-C Nova Southeastern University

Components of the Preoperative Evaluation

• Personal Interview• Review of systems• Prior anesthetic experience (Difficult intubation, delayed

emergence, MH, delayed NMB, PONV)• Drug allergies

• Physical Examination• Airway exam• Body habitus

• Review of Medical Records• Medications• Substance use (alcohol, tobacco, illicit)• Surgical history• Surgical Diagnosis (Organ systems involved, Planned

procedure)

Page 6: Preoperative Evaluation and Management with Cardiac Evaluation Lauren Hojdila, MSA, AA-C Nova Southeastern University

ASA ClassificationClass 1: Healthy patient, No medical problems

Class 2: Mild systemic disease

Class 3: Severe systemic disease, but not incapacitating

Class 4: Severe systemic disease that is a constant threat to life

Class 5: Moribund, not expected to live 24 hours irrespective of operation

Class 6: Organ donor

E may be added to the status number to designate an emergency operation

Page 7: Preoperative Evaluation and Management with Cardiac Evaluation Lauren Hojdila, MSA, AA-C Nova Southeastern University

Thyromental DistanceAirway Examination

• Distance from the thyroid cartilage to the inside of the mentum

• Measured with the neck in the sniff position

• What is normal thyromental distance?

A higher Mallampati class combined with a mental distance <2 finger-breadthsmay better predict increased difficulty with intubation.

Page 8: Preoperative Evaluation and Management with Cardiac Evaluation Lauren Hojdila, MSA, AA-C Nova Southeastern University

Mallampati ClassificationAirway Examination

• Class I: Soft palate, fauces, uvula, tonsillar

pillars• Class II: Soft palate, fauces, uvula• Class III: Soft palate, base of uvula• Class IV: Hard palate only

Page 9: Preoperative Evaluation and Management with Cardiac Evaluation Lauren Hojdila, MSA, AA-C Nova Southeastern University

What other feature increase the likelihood of difficult intubation?

• Short, thick neck (Neck circumference)

• Diminished neck extension• Decreased tissue compliance• Large tongue• Teeth (Overbite, Large teeth)• Decreased TMJ mobility

Page 10: Preoperative Evaluation and Management with Cardiac Evaluation Lauren Hojdila, MSA, AA-C Nova Southeastern University

NPO Guidelines

• Healthy Adults (No risk factors)• No solid foods for a minimum of 6 hours• Clear liquids up to 2 hours prior to elective

case• Oral medications up to 1-2 hours with sip of

water

• Pediatric patients• Clear liquids up to 2 hours preOp• Breast milk up to 4 hours preOp• Solid foods, nonhuman milk, formula up to 6

hours preOp

Page 11: Preoperative Evaluation and Management with Cardiac Evaluation Lauren Hojdila, MSA, AA-C Nova Southeastern University

AspirationWho has a higher risk ?

• Gastrointestinal Obstruction• GERD• Diabetes mellitus• Recent solid-food intake• Abdominal distention• Pregnancy• Depressed consciousness• Recent opioid administration• Upper GI or naso-oropharyngeal bleeding, with or

without trauma• Emergency surgery

Page 12: Preoperative Evaluation and Management with Cardiac Evaluation Lauren Hojdila, MSA, AA-C Nova Southeastern University

The Healthy PatientSystems Approach

• Airway• Examination as previously described

• Pulmonary• History – Tobacco use, asthma, SOB/DOE, sleep apnea,

wheezing, cough, etc.• Physical exam – Lung sounds, chest excursion, use of

accessory muscles, cyanosis, clubbing, etc.

• Cardiovascular• HTN, CAD, MI, angina, CHF, dysrhythmias, valvular dx,

heart sounds, carotid bruits, peripheral pulses

• Neurologic• Mental status, h/o seizures, neuromuscular disease, nerve

injury

• Endocrine• Diabetes mellitus, thyroid disease, adrenal cortical

suppression, etc.

Page 13: Preoperative Evaluation and Management with Cardiac Evaluation Lauren Hojdila, MSA, AA-C Nova Southeastern University

The Patient with Known Cardiac Disease

• Define risk– Goldman risk index (Independent

predictors)• High-risk surgery, h/o ischemic heart dx, h/o

CHF, h/o cerebrovascular dx, preOp insulin therapy, and preOp serum creatinine > 2 mg/dL

• Need for further testing• Recent MI or ECG changes• Poor exercise tolerance

• Need for cardiac surgery• Prior to current elective surgery

Page 14: Preoperative Evaluation and Management with Cardiac Evaluation Lauren Hojdila, MSA, AA-C Nova Southeastern University

The Patient withPulmonary Disease

• Site and Type of Surgery• Thoracic and upper abdominal procedures are

associated with increased pulmonary complications

• Type and Severity of Disease• Does the disease have a reversible component ?• When were they last hospitalized ?

• Interview• Exercise tolerance, chronic cough, smoking history• What are their current treatment modalities?

• Physical Exam• Lungs sounds – wheezing, rhonchi, decreased breath

sounds

Page 15: Preoperative Evaluation and Management with Cardiac Evaluation Lauren Hojdila, MSA, AA-C Nova Southeastern University

Other Diseases of Concern

• Diabetic Mellitus• Increased risk of CAD, perioperative MI,

hypertension, and CHF• Consider beta-blockade in diabetics with CAD to help

limit myocardial ischemia

• Renal Disease• Altered drug metabolism• Fluid management

• Liver Disease• Coagulation abnormalities• Altered protein binding and volume of distribution

Page 16: Preoperative Evaluation and Management with Cardiac Evaluation Lauren Hojdila, MSA, AA-C Nova Southeastern University

PerioperativeLab Testing

• No evidence supports the use of routine laboratory testing

• There is support for the use of selected lab analysis based on the patient’s preOp history, physical exam, and proposed surgical procedure

• A positive result is frequently a false-positive• High incidence of false-positives when performing tests in

normal patients (a population with a very low prevalence of disease)

• Risk/Cost vs. Benefit• Medical testing is associated with significant cost• The risk of intervention may outweigh the benefit

• Is it going to change what you do ???

Page 17: Preoperative Evaluation and Management with Cardiac Evaluation Lauren Hojdila, MSA, AA-C Nova Southeastern University

Recommended Lab Tests

• CBC / Hemoglobin• Hgb of 7 g/dL is acceptable in patients without systemic

disease (depending upon proposed surgical procedure)• In patients with systemic disease, signs of inadequate

systemic oxygen delivery are an indication for transfusion

• Electrolytes• Creatinine and glucose in older asymptomatic adults• BUN and creatinine in patients with systemic disease or

on medications that affect the kidneys

• Coagulation Studies• Recommended in patients with bleeding disorders, liver

dysfunction, or on anticoagulant therapy

Page 18: Preoperative Evaluation and Management with Cardiac Evaluation Lauren Hojdila, MSA, AA-C Nova Southeastern University

Recommended Lab TestsContinued

• Pregnancy Testing• Current practice:

– testing all females of child-bearing age

• Chest X-rays• Routine testing in the population without

risk factors can lead to more harm than good• Is indicated in patients with a history or

clinical evidence of active pulmonary disease, and may be indicated routinely in patients of advanced age

Page 19: Preoperative Evaluation and Management with Cardiac Evaluation Lauren Hojdila, MSA, AA-C Nova Southeastern University

Preoperative Medications

• What is the goal of premedication ?• Anxiolysis, Sedation, Amnesia, Analgesia, etc.

• What drug, when, and how much ?• Several classes of drugs may be available to facilitate

the desired goal• Timing of drug delivery is as important as drug selection

• There is no BEST drug or combination of drugs for preoperative medication

• The specific drugs selected are based on the goals of premedication balanced with the potential side effects these drugs may produce

Page 20: Preoperative Evaluation and Management with Cardiac Evaluation Lauren Hojdila, MSA, AA-C Nova Southeastern University

Preoperative Medications

• Benzodiazepines• Act on GABA receptors to produce selective

anxiolysis at doses that do not produce excessive sedation, depression of ventilation, or adverse cardiac effects• Note: May lead to any of the above when

given with opioids

• Opioids• Should be used when there is a need to

provide analgesia

Page 21: Preoperative Evaluation and Management with Cardiac Evaluation Lauren Hojdila, MSA, AA-C Nova Southeastern University

Preoperative MedicationsContinued

• Antiemetics• Administered in the preOp or intraOp period as

prophylaxis against PONV• Droperidol (Black-Boxed), Reglan (? Antiemetic), 5HT3

inhibitors, Decadron, Scopolamine patch (apply several hours before induction of anesthesia)

• Drugs used to alter gastric volume/pH• Clinically significant pulmonary aspiration of gastric

fluid is rare in healthy patients undergoing elective surgery, maintenance of a patent airway is more important than routine pharmacologic prophylaxis

• Use in patients with specific indications

Page 22: Preoperative Evaluation and Management with Cardiac Evaluation Lauren Hojdila, MSA, AA-C Nova Southeastern University

What has changed about your plan?

• Airway• Medications• Trends of Vital Signs

Page 23: Preoperative Evaluation and Management with Cardiac Evaluation Lauren Hojdila, MSA, AA-C Nova Southeastern University

Pre-Operative Cardiac Evaluation

Page 24: Preoperative Evaluation and Management with Cardiac Evaluation Lauren Hojdila, MSA, AA-C Nova Southeastern University

Cardiovascular Disease

• During a lifetime, a heart contracts more than 4 billion times – To support the active cardiac state, the

heart supplies more than 4 million liters of blood to the myocardium and more than 200 million liters to the systemic circulation

• Cardiac output can vary from 3 L/min to 30 L/min depending on activity level – Regional blood flow can vary up to 200%

Page 25: Preoperative Evaluation and Management with Cardiac Evaluation Lauren Hojdila, MSA, AA-C Nova Southeastern University

Cardiovascular DiseaseMajor Disease Categories

• Coronary heart disease (CHD/CAD)• Hypertension (HTN)

• Rheumatic heart disease (RHD)• Bacterial endocarditis• Congenital heart disease

Page 26: Preoperative Evaluation and Management with Cardiac Evaluation Lauren Hojdila, MSA, AA-C Nova Southeastern University

Coronary Heart Disease

• Leading cause of death in the United States

• Around 1 million deaths per year from cardiovascular pathology

• About ½ of these related to ischemic disease

• No. 1 cause of death among women in the U.S.

• Lifetime risk of death from CHD: 31%• Lifetime risk of death from breast CA: 2.8%

Page 27: Preoperative Evaluation and Management with Cardiac Evaluation Lauren Hojdila, MSA, AA-C Nova Southeastern University

Coronary Heart DiseaseRisk Factors

• Past medical history• Chronic disorder

– Hypertension– Hyperlipidemia– Diabetes mellitus– Thyroid dysfunction

• Cardiac surgery• Rhythm disorder• Acute rheumatic fever

Page 28: Preoperative Evaluation and Management with Cardiac Evaluation Lauren Hojdila, MSA, AA-C Nova Southeastern University

Coronary Heart DiseaseRisk Factors: Family History

• Diabetes mellitus• Heart disease• Hypertension• Congenital heart defects

– Particularly VSD

• Sudden death• Early age cardiovascular disease

Page 29: Preoperative Evaluation and Management with Cardiac Evaluation Lauren Hojdila, MSA, AA-C Nova Southeastern University

Coronary Heart DiseaseRisk Factors: Social History

• Stressful or physical work• Tobacco use• Poor nutritional status• “High strung” personality• Lack of relaxing activities• Use of alcohol• Use of illegal drugs

Page 30: Preoperative Evaluation and Management with Cardiac Evaluation Lauren Hojdila, MSA, AA-C Nova Southeastern University

Preoperative Clinical Evaluation

Identification of serious cardiac disorderCAD, CHF, ArrhythmiasInitial history, Physical examination, ECG

Define disease severity, stability, and prior treatmentFunctional capacityAgeComorbidities

DM, peripheral vascular disease, renal dysfunction, chronic pulmonary disease

Type of surgeryConsider higher risk

Vascular proceduresProlonged complicated thoracic, abdominal and head and neck

procedures

Page 31: Preoperative Evaluation and Management with Cardiac Evaluation Lauren Hojdila, MSA, AA-C Nova Southeastern University

HypertensionManagement of Preoperative Cardiovascular Conditions

• Severe Htn(DBP >110mmHg) should be controlled before surgery when possible

• Continuation of preoperative antihypertensive treatment is critical to avoid severe postoperative hypertension.

• Consider the urgency of surgery and the potential benefit of more intensive medical therapy.

Page 32: Preoperative Evaluation and Management with Cardiac Evaluation Lauren Hojdila, MSA, AA-C Nova Southeastern University

Valvular Heart DiseaseManagement of Preoperative Cardiovascular Conditions

• Symptomatic stenotic lesions (MS or AS): associated with risk of perioperative severe CHF or shock and often require percutaneous valvotomy or replacement to lower cardiac risk.

• Symptomatic regurgitant lesions (AR or MR): usually better tolerated perioperatively and may be stabilized before surgery with intensive medical therapy and monitoring

Page 33: Preoperative Evaluation and Management with Cardiac Evaluation Lauren Hojdila, MSA, AA-C Nova Southeastern University

Myocardial Heart DiseaseManagement of Preoperative Cardiovascular Conditions

• Dilated and hypertrophic cardiomyopathy are associated with an increased incidence of perioperative CHF.

• Maximizing preoperative hemodynamic status and providing intensive postoperative medical therapy and surveillance.

Page 34: Preoperative Evaluation and Management with Cardiac Evaluation Lauren Hojdila, MSA, AA-C Nova Southeastern University

Arrhythmias and Conduction AbnormalitiesManagement of Preoperative Cardiovascular Conditions

• Careful evaluation for underlying cardiopulmonary disease, drug toxicity, or metabolic abnormality.

• Therapy: reverse any underlying cause and treat the arrhythmia

Page 35: Preoperative Evaluation and Management with Cardiac Evaluation Lauren Hojdila, MSA, AA-C Nova Southeastern University

Medical Therapy for Coronary Artery Disease

• If patients require β-blockers, calcium channel blockers, or nitrates before surgery, continue them into the operative and post-op period.

• The same is true for therapies used to control CHF

• β-blockers reduce postoperative ischemia– Protection against ischemia may also

reduce risk of MI

Page 36: Preoperative Evaluation and Management with Cardiac Evaluation Lauren Hojdila, MSA, AA-C Nova Southeastern University

Cardiac Evaluation

• Clinical predictors

• Functional capacity

• Surgical risk

• Non-invasive testing

• Invasive testing

Page 37: Preoperative Evaluation and Management with Cardiac Evaluation Lauren Hojdila, MSA, AA-C Nova Southeastern University

Method of Assessing Cardiac Risk

• Resting Left Ventricular Function

• Exercise Stress Testing

• Pharmacological Stress Testing

• Ambulatory EKG monitoring

• Coronary Angiography

Page 38: Preoperative Evaluation and Management with Cardiac Evaluation Lauren Hojdila, MSA, AA-C Nova Southeastern University

Clinical Predictors of Increased Perioperative Cardiovascular Risk

(Myocardial Infarction, Congestive Heart Failure, Death)

• MinorAdvanced ageAbnormal EKG(LVH, LBBB, ST-T abnormalities)Rhythm other than sinus (eg, atrial fibrillation)Low functional capacity (eg, unstable to climb one flight of stairs

with a bag of groceries)History of strokeUncontrolled systemic hypertension

• IntermediateMild angina pectoris(Canadian Cardiovascular Society Class I or

II)Prior myocardial infarction by history or pathological wavesCompensated or prior CHFDiabetes mellitus

Page 39: Preoperative Evaluation and Management with Cardiac Evaluation Lauren Hojdila, MSA, AA-C Nova Southeastern University

Clinical Predictors of Increased Perioperative Cardiovascular Risk

(Myocardial Infarction, Congestive Heart Failure, Death)

• MajorUnstable coronary syndromes– Recent myocardial infarction with evidence of important

ischemic risk by clinical symptoms or noninvasive study– Unstable or severe angina– Decompensated CHF

Significant arrhythmias– High grade atrioventricular block– Symptomatic ventricular arrhythmias in the presence of

underlying heart disease– Supraventricular arrhythmias with uncontrolled

ventricular rate

Severe valvular disease

Page 40: Preoperative Evaluation and Management with Cardiac Evaluation Lauren Hojdila, MSA, AA-C Nova Southeastern University

Functional Capacity

1 MET1 MET Can you take care of yourself?Can you take care of yourself?

Can you eat, dress, or use the toilet?Can you eat, dress, or use the toilet?

Can you walk indoors around the house?Can you walk indoors around the house?

Can you walk a block or two on level ground at 2-3 mph?Can you walk a block or two on level ground at 2-3 mph?

Can you do light housework, such as dusting or washing dishes?Can you do light housework, such as dusting or washing dishes?

4 METs4 METs Can you climb a flight of stairs or walk up a hill?Can you climb a flight of stairs or walk up a hill?

Can you walk on level ground at 4 mph?Can you walk on level ground at 4 mph?

Can you run a short distance?Can you run a short distance?

Can you do heavy housework, such as scrubbing floors or lifting or moving Can you do heavy housework, such as scrubbing floors or lifting or moving heavy furniture?heavy furniture?

Do you participate in moderate recreational activities, such as golf, bowling, Do you participate in moderate recreational activities, such as golf, bowling, dancing, doubles tennis, or throwing a baseball or football?dancing, doubles tennis, or throwing a baseball or football?

>10 METs>10 METs Do you participate in strenuous sports, such as swimming, singles tennis, Do you participate in strenuous sports, such as swimming, singles tennis, football, basketball, or skiing?football, basketball, or skiing?

Page 41: Preoperative Evaluation and Management with Cardiac Evaluation Lauren Hojdila, MSA, AA-C Nova Southeastern University

Surgical RiskLow Risk Procedures

• Low surgical risk:– Endoscopy– Bronchoscopy– Cystoscopy– Dermatologic procedures– Breast biopsy– Opthalmologic procedures

Page 42: Preoperative Evaluation and Management with Cardiac Evaluation Lauren Hojdila, MSA, AA-C Nova Southeastern University

Surgical Risk

• Intermediate surgical risk:– Orthopedic surgery– Urologic surgery– Uncomplicated abdominal surgery– Uncomplicated head and neck

Page 43: Preoperative Evaluation and Management with Cardiac Evaluation Lauren Hojdila, MSA, AA-C Nova Southeastern University

Surgical Risk

• High surgical risk:– Emergency surgery– Cardiac procedures– Aortic or vascular surgery– Anticipated prolonged surgery• Large fluid shifts or blood loss• Ex: Whipple, spinal surgery

Page 44: Preoperative Evaluation and Management with Cardiac Evaluation Lauren Hojdila, MSA, AA-C Nova Southeastern University

ElectrocardiogramSignificant ECG Findings

• Past myocardial infarction• Left bundle branch block• Bifasicular block• Atrioventricular block –Mobitz-Type II or 3°AVB

• Prolonged QT interval• Right ventricular hypertrophy

Page 45: Preoperative Evaluation and Management with Cardiac Evaluation Lauren Hojdila, MSA, AA-C Nova Southeastern University

Echocardiography

• Displays 2-dimensional ultrasound images of the heart

• Can be used to produce accurate assessment of the velocity of blood and cardiac tissue– Utilizes pulse wave Doppler ultrasound

• Diagnostic uses:– Wall motion abnormalities– Valvular dysfunction (valve area and function)– Septal defects– Calculation of cardiac output and ejection fraction

Page 46: Preoperative Evaluation and Management with Cardiac Evaluation Lauren Hojdila, MSA, AA-C Nova Southeastern University

EchocardiographyTypes of Echocardiography

• Transthoracic (TTE)

• Exercise stress echo

• Dobutamine stress echo

• Transesophageal (TEE)

Page 47: Preoperative Evaluation and Management with Cardiac Evaluation Lauren Hojdila, MSA, AA-C Nova Southeastern University

Stress Testing

• Used to evaluate myocardial perfusion during stress as compared to at rest

• Diagnostic usefulness debatable! • Types of evaluation:– Exercise (a.k.a. treadmill)– Dobutamine or adenosine– Radiotracer

• Tc99m Sestamibi (Cardiolite®)• Thallium

Page 48: Preoperative Evaluation and Management with Cardiac Evaluation Lauren Hojdila, MSA, AA-C Nova Southeastern University

Cardiac Catheterization• Invasive angiography of myocardial

perfusion• Diagnostic usefulness:– Arterial occlusion– Thrombotic lesions– Aneurysmal enlargement

• Concurrent procedures:– Percutaneous transluminal coronary

angioplasty (PTCA)– Coronary artery stent placement– Dissection and stroke

Page 49: Preoperative Evaluation and Management with Cardiac Evaluation Lauren Hojdila, MSA, AA-C Nova Southeastern University

Need for noncardiac

surgeryO.R.emergency

Postoperative risk stratification and

risk factor management

Urgent or elective

Coronary revascularization

within 5 yrs

Recurrent symptoms or

signs

Recent coronary

evaluation

Recent coronary angiogram or

stress test?

Intermediate

Clinical predictors

Major Minor or No

O.R.

yes

Unfavorable result and change in symptoms

Favorable result and no change in symptoms

no

no

yes

yes

no

Stepwise Approach to Stepwise Approach to Preoperative Cardiac Preoperative Cardiac

AssessmentAssessment

Page 50: Preoperative Evaluation and Management with Cardiac Evaluation Lauren Hojdila, MSA, AA-C Nova Southeastern University

Minor or no clinical predictors

Poor(<4METs) Moderate or excellent(>4METs)

High surgicalrisk procedure

Intermediatesurgical riskprocedure

Noninvasive testing O.R. Postoperative management

Subsequent care by findings and treatment results

Consider coronary angiography Minor clinical predictors:•Advanced age•Abnormal ECG•Rhythm other than sinus•Low functional capacity•History of stroke•Uncontrolled systemic hypertension

High risk

low risk

Stepwise Approach to Stepwise Approach to Preoperative Cardiac Preoperative Cardiac

AssessmentAssessment

Page 51: Preoperative Evaluation and Management with Cardiac Evaluation Lauren Hojdila, MSA, AA-C Nova Southeastern University

Intermediate clinical predictors:•Mild angina pectoris•Prior MI•Compensated or prior CHF•DM

Intermediate clinical predictors

Poor(<4METs)

Moderate or excellent(>4METs)

High surgicalrisk procedure

Intermediate or lowsurgical procedure

Low surgicalrisk procedure

Noninvasivetesting

O.R. Postoperative risk stratificationand risk factor reduction

Consider coronaryangiography

Subsequent care dictated by findingsand treatment results

Low risk

High risk

Stepwise Approach to Stepwise Approach to Preoperative Cardiac Preoperative Cardiac

AssessmentAssessment

Page 52: Preoperative Evaluation and Management with Cardiac Evaluation Lauren Hojdila, MSA, AA-C Nova Southeastern University

Major clinical predictors:•Unstable coronary syndromes•Decompensated CHF•Significant arrhythmias•Severe valvular disease

Major clinical predictors

Delay or cancel noncardiac surgery

Medical managementand risk factor modification

Coronaryangiography

Subsequent care dictated by findingsand treatment results

Stepwise Approach to Stepwise Approach to Preoperative Cardiac Preoperative Cardiac

AssessmentAssessment

Page 53: Preoperative Evaluation and Management with Cardiac Evaluation Lauren Hojdila, MSA, AA-C Nova Southeastern University

Summary

• How has the information gained in the pre-op evaluation changed your plan?

• Is there anything further that you need to deliver a safe anesthetic?

• Should you proceed with the case?• Don’t forget to monitor closely.• Have a back-up plan ready to

implement.